Paul M Kiproff, MD

Predictive Oncology, based in Pittsburgh, PA, is a pioneering company at the forefront of oncology drug discovery and development. Through their innovative AI-driven platform, PEDAL, which utilizes a biobank of over 150,000 tumor samples, Predictive Oncology is revolutionizing the field by predicting drug responses with 92% accuracy and increasing the probability of success in drug development. With a focus on bringing the human element into oncology drug development earlier, Predictive Oncology's cutting-edge approach allows for the repurposing of failed drug compounds, improved portfolio diversity, and optimized drug-tumor pairing. Their groundbreaking work with disruptive technology is shaping the future of oncology research and paving the way for more confident predictions in drug response outcomes.Generated from the website

The Department of Immunology at the University of Pittsburgh is dedicated to advancing the understanding of the immune system and its role in human health. Through cutting-edge research and training programs, the department aims to combat and prevent diseases, enhance vaccination, and control autoimmunity. With a focus on discovering new mechanisms and pathways of the immune system, the department strives to improve the well-being of individuals by harnessing the power of immunology. With a rich history and a commitment to excellence, the Department of Immunology offers a range of educational opportunities for students, postdoctoral fellows, physicians, and young scientists. Through seminars, research series, and special events, the department fosters a collaborative environment for the exchange of knowledge and ideas. Supported by state-of-the-art core facilities, the department's research efforts are aimed at unraveling the complexities of the immune system and finding innovative solutions to combat diseases such as diabetes, lupus, multiple sclerosis, rheumatoid arthritis, and atherosclerosis.Generated from the website